Similar to the effects of IL-1R1 deletion, anti-IL-1R1 antibody treatment significantly decreased leukocytosis and splenomegaly and markedly reduced BM fibrosis in homozygous Jak2V617F mice. The gene discussed is IL1R1; the disease is Splenomegaly.